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The precise regulation of programmed cell death is
critical for the normal development of the nervous
system.Weshowhere thatDYRK1A (minibrain), apro-
tein kinase essential for normal growth, is a negative
regulator of the intrinsic apoptotic pathway in the
developing retina. We provide evidence that changes
inDyrk1A gene dosage in themouse strongly alter the
cellularity of inner retina layers and result in severe
functional alterations. We show that DYRK1A does
not affect the proliferation or specification of retina
progenitor cells, but rather regulates the number of
cells that die by apoptosis. We demonstrate that
DYRK1A phosphorylates caspase-9 on threonine
residue 125, and that this phosphorylation event is
crucial to protect retina cells from apoptotic cell
death. Our data suggest a model in which dysregula-
tion of the apoptotic response in differentiating neu-
rons participates in the neuropathology of diseases
that displayDYRK1Agene-dosage imbalance effects,
such as Down’s syndrome.
INTRODUCTION
Proliferation, differentiation, and apoptosis are fundamental
cellular processes in the development of central nervous system
(CNS) structures. These processes need to be tightly regulated
and coordinated during neurogenesis to produce the correct
numbers of each of the many neuronal cell types of the mature
CNS. Alterations in these processes result in an altered neuronal
circuitry and underlie many human neurodevelopmental dis-
eases. Because of its accessibility and relatively low cellular
complexity compared with the brain, the retina has long been
used as a model system by which to study CNS development
(Donovan and Dyer, 2005). Retina cells are generated from
a pool of common precursors, the retina progenitor cellsDevelopm(RPCs), that exit the cell cycle and acquire a specific cell fate
in a precise spatial and temporal order that depends on both
intrinsic and extrinsic factors (Cepko, 1999; Harris, 1997; Livesey
and Cepko, 2001; Marquardt and Gruss, 2002). Another crucial
event during retina development is the correct execution of pro-
grammed cell death (PCD); cells are produced in excess during
neurogenesis and are later eliminated in a series of ordered
apoptotic waves (Boya and de la Rosa, 2005; Cellerino et al.,
2000; Young, 1984). Although the process of PCD and the main
components of the apoptotic cascade involved in retina develop-
ment have been identified, little is known about the molecular
mechanisms that precisely regulate the execution of the apopto-
tic program.
DYRK1A is a protein kinase that belongs to an evolutionarily
conserved family of proteins known as DYRKs (dual-specificity
tyrosine-(Y)-phosphorylation-regulated kinase) involved in func-
tions generally related with growth and/or development (Becker
and Joost, 1999). Loss-of-function mutations in mouse Dyrk1A
(Fotaki et al., 2002) and in its homolog in Drosophila mela-
nogaster (minibrain [mnb]) (Tejedor et al., 1995) showed that
Dyrk1A/mnb are regulators of body growth. Dyrk1A and mnb
mutants both have decreased body size, and their brains are
disproportionately reduced, with some areas more severely
affected than others: for example, the mesencephalic tectum
in the mouse and the optic lobes in the fly. Interestingly, truncat-
ing mutations of human DYRK1A in heterozygosity results in
microcephaly (Moller et al., 2008), confirming that this is a dos-
age-sensitive gene important for normal brain development.
Brain size reduction in mnb flies seems to be caused by
a decrease in the number of neuronal cells generated during
postembryonic development (Tejedor et al., 1995). In verte-
brates, DYRK1A expression patterns also point to a possible
role for this kinase in the proliferation of neural precursor cells.
Mouse and chick Dyrk1A mRNAs are expressed in neuroepithe-
lial cells from the early stages of CNS development and are
asymmetrically distributed during the mitosis of neuronal
progenitor cells (Hammerle et al., 2002, 2008). A series of other
studies has also indicated a role of DYRK1A in neuronal differen-
tiation (Arron et al., 2006; Kelly and Rahmani, 2005; Yang et al.,ental Cell 15, 841–853, December 9, 2008 ª2008 Elsevier Inc. 841
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et al., 2003; Wegiel et al., 2004), and the implication in synaptic
activity of two DYRK1A-regulated transcription factors, NFAT
(Arron et al., 2006) and CREB (Yang et al., 2001), indicate that
DYRK1A might have a role in the maintenance of adult brain
neuronal activity.
Human DYRK1A maps within the Down’s syndrome (DS)
critical region on chromosome 21 (HSA21) (Delabar et al.,
1993; Guimera et al., 1996) and is overexpressed in tissues of
DS fetuses (Guimera et al., 1999). A contribution of DYRK1A
overexpression to the DS phenotype is supported by the brain
phenotypes observed in mouse animal models (Delabar et al.,
2006). Despite the importance of DYRK1A in CNS development
and its implication in human genetic diseases, the molecular
mechanisms underlying the impact of DYRK1A gene-dosage
imbalance in vivo remain largely unknown. The observation
that DYRK1A is expressed in the developing retina (Hammerle
et al., 2008; Song et al., 1996), and the fact that infants and adults
with DS show visual impairments (Courage et al., 1994; John
et al., 2004; Little et al., 2007; Woodhouse et al., 1996) prompted
us to investigate DYRK1A function in the retina.
We show here that DYRK1A is critical for correct retina devel-
opment, and that variations in Dyrk1A gene dosage lead to
profound alterations in retinal activity that can be attributed
to severe changes in retinal cellularity. We provide evidence
that DYRK1A kinase activity regulates the phosphorylation of
caspase-9 (Casp9) at threonine residue 125 (Thr125), and that
this regulatory event is decisive for the execution of the intrinsic
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Figure 1. Expression of DYRK1A in the Developing and Adult Mouse
Retina
(A–C) Immunostaining of DYRK1A (green) and proliferating cell nuclear antigen
(PCNA, red) in retina sections from wild-type (A) E12.5 and (B) E18.5 embryos
and (C) PND6 mice. Asterisks in (C) indicate the nascent plexiform layers. nr,
neuroretina; L, forming lens. Scale bars are 40 mm.
(D–H) Immunostaining of DYRK1A (green) in retina sections from wild-type
adult mice. Cell nuclei are stained with TOPRO-3 (blue) in (D). Red staining
shows the expression of the (E) synaptic vesicular protein synaptophysin,
the (F) rod BP cell marker PKCa, the (G) RGC cell marker Brn3b, and the (H)
AMA cell marker Pax6. Scale bars are 40 mm in (D), 20 mm in (E) and (F), and
10 mm in (G) and (H). S, photoreceptor segments.
(I) Representative staining of a retina section (wild-type PND6 mouse) in which
the primary polyclonal DYRK1A antibody has been omitted from the incuba-
tion solution. The specificity of the DYRK1A antibody is shown in Figures
S1A and S1B. The scale bar is 40 mm.842 Developmental Cell 15, 841–853, December 9, 2008 ª2008 Elsapoptotic program. Our results therefore show a function
for DYRK1A in the fine regulation of apoptotic processes
that are essential for nervous system development and that
could be underlying the neuropathology of diseases such
as DS.
RESULTS
DYRK1A Is Expressed in the Mouse Retina
Dyrk1A expression in the optic vesicle and the neuroretina has
been previously shown in mouse embryos by in situ hybridiza-
tion (Fotaki et al., 2002; Hammerle et al., 2008; Song et al.,
1996). We first studied whether this correlates with expression
at the protein level. At embryonic day (E) 12.5, DYRK1A expres-
sion was homogeneously distributed throughout the retina neu-
roepithelium (Figure 1A). At E18.5, DYRK1A was still found
throughout the retina and was mainly restricted to the cytoplasm
of both proliferating and postmitotic retina cells (Figure 1B). At
postnatal day (PND) 6, DYRK1A expression was high in the
two emerging plexiform layers and in cell bodies of the ganglion
cell layer (GCL) (Figure 1C). In the adult retina, DYRK1A expres-
sion was found in the inner and outer segments of photorecep-
tor (PR) cells, in the neuronal processes of the outer plexiform
(OPL) and inner plexiform (IPL) layers, in cell bodies of the
GCL, and, at lower levels, in the inner nuclear layer (INL)
(Figure 1D; see Figure S1C available online). Double immunoflu-
orescence with antibodies specific for cells of the INL and of the
GCL showed expression of DYRK1A in the soma of all cell types
analyzed (Figures 1F–1H). A faint DYRK1A punctate staining
was visible in the nuclei of some Brn3b-positive ganglion
cells (RGCs) and Pax6-positive amacrine (AMA) cells (Figures
1G and 1H). DYRK1A was also detected in PR terminals
and in dendrites of rod bipolar (BP) cells in the OPL (Figures
1D–1F), in terminals of AMA cells (data not shown), and in
axon terminals of rod BP cells in the INL (Figure 1F). This tempo-
ral and spatial expression pattern of DYRK1A suggests a role
for this protein both during development and in the mature
retina.
Electroretinograms Reveal Altered Retina Function
in Dyrk1A+/ and tgYAC152f7 Mice
To determine the possible effects of DYRK1A on retina function,
we used mouse models carrying either one Dyrk1A mutant allele
(Dyrk1A+/ mice) (Fotaki et al., 2002), or three copies of the YAC
clone 152f7 (tgYAC152f7 mice), which, in addition to human
DYRK1A, contains four other HSA21 genes (Branchi et al.,
2004; Smith et al., 1997). Both strains of mice show significant
brain morphological alterations and behavioral abnormalities
(Arque et al., 2008; Benavides-Piccione et al., 2005; Branchi
et al., 2004; Fotaki et al., 2002, 2004; Smith et al., 1997) that, in
the case of tgYAC152f7, have been attributed to the increased
dosage of DYRK1A (Smith et al., 1997). As expected, the abun-
dance of DYRK1A protein is reduced in Dyrk1A heterozygous
retinas and increased in tgYAC152f7 retinas compared with
age-matched control disomic retinas at any developmental
stage analyzed (Figures S2A and S2B).
To assess retina function, a series of electroretinogram (ERG)
experiments was performed on adultDyrk1A+/ and tgYAC152f7
mice, and on their corresponding control littermates: Dyrk1A+/+evier Inc.
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DYRK1A Regulates Apoptosis in Mouse Retinaand wild-type, respectively (Figure 2; Table S1). The rod-driven
circuitry was tested under scotopic conditions (dim light). The
amplitude of the scotopic b-wave (bdim,scot), which arises primar-
ily from rod BP cells (Pugh et al., 1998), showed significant differ-
ences between wild-type and mutant mice (Figures 2A and 2F):
a reduction in the bdim,scot in the loss-of-function animals and an
increase in the gain-of-function animals. Under scotopic condi-
tions, light stimuli of high intensity evoked mixed responses.
The a-wave amplitude measured in these conditions (amix,scot)
reflects the functionality of rod and cone PR (Pugh et al.,
1998). Figure 2B shows the retina responses to high-intensity
light stimuli of Dyrk1A+/ and Dyrk1A+/+ mice; although there
were no significant differences in the averaged amix,scot between
the two genotypes, b-wave amplitudes measured in response
to high-intensity stimuli (bmix,scot) were significantly lower in
Dyrk1A+/ mice. Interestingly, tgYAC152f7 mice showed signifi-
cant differences in the mixed response (Figure 2G) both in the
amix,scot and bmix,scot amplitudes, which were larger than in the
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Figure 2. AlteredRetinaActivity inDyrk1A+/
and tgYAC152f7 Mice
(A–J) Representative ERG recordings obtained
from one Dyrk1A+/+ (dark traces) and one
Dyrk1A+/ (gray traces) mouse (left column) and
from one wild-type (dark traces) and one
tgYAC152f7 (gray traces) mouse (right column):
rod-mediated responses (in [A] and [F]); mixed
rod and cone responses (in [B] and [G]); oscillatory
potentials (in [C] and [H]); cone mediated
responses (in [D] and [I]); and flicker responses
(in [E] and [J]). Calibration groups: A-B-F-G, C-D-
H-I, and E-J. The mean values of all of the record-
ings and the statistical significance are included in
Table S1.
controls. To determine the contribution
of third-order neurons to light-induced
ERG, oscillatory potentials (OPs) were
isolated from the electrophysiological
recordings. OPs reflect extracellular elec-
trical currents generated by negative-
feedback pathways between AC, RGC,
and BP cells at the IPL, although their
exact cellular origin is not yet known
(Wachtmeister and Dowling, 1978). The
OPs recorded in response to high-inten-
sity light stimuli under scotopic condi-
tions showed a significant decrease in
the maximum amplitude (peak to peak
OP) in Dyrk1A+/ mice (Figure 2C) and
a significant increase in tgYAC152f7
mice (Figure 2H) compared with their cor-
responding control littermates.
The cone-driven circuitry was tested
under photopic conditions by measuring
the ERG response to intense flashes of
light in the presence of rod-saturating
light stimulation. Photopic b-wave re-
sponses recorded to light stimuli of very
high intensity (bphot) are represented in Figures 2D and 2I. A sig-
nificant decrease in the photopic b-wave was measured in
Dyrk1A+/ animals, whereas an increase was measured in
tgYAC152f7 animals. Finally, we tested ERG responses to high
frequency flicker stimuli (20 Hz). Flicker response is primarily
generated by cone PR (Kondo and Sieving, 2001). Whereas
Dyrk1A+/ animals presented a slight, although not significant,
decrease in their flicker responses (Figure 2E), tgYAC152f7
animals presented a significant increase compared with their
corresponding controls (Figure 2J). Average data on ERG
wave amplitudes and statistically significant differences are
shown in Table S1. These data indicate that retina electrical
activity is decreased in Dyrk1A loss-of-function mutants and
augmented in tgYAC152f7 mice. As the most significantly
altered responses in both mouse strains arise from cells
postsynaptic to rod and cone PR, our results suggest that
changes in Dyrk1A dosage particularly affect inner retina cells
functionality.
Developmental Cell 15, 841–853, December 9, 2008 ª2008 Elsevier Inc. 843
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Retinas
The morphological brain alterations shown by Dyrk1A+/ and
tgYAC152f7 mice suggest that structural abnormalities affecting
the retina circuitry could be at the basis of the altered electrophy-
siologycal responses measured here in both mutant strains. To
assess this possibility, we performed a morphometric analysis
of the eyes of 2-month-old Dyrk1A+/ and tgYAC152f7 mice.
Dyrk1A+/ eyes are smaller than those of their corresponding
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Figure 3. Changes in Dyrk1A Gene Dosage
Result in Severe Alterations of Retina Cell
Numbers
(A) Representative medial retina sections from
mice of the four genotypes yielded by crossing
Dyrk1A+/ and tgYAC152f7-B mice. Notice the
alterations in INL and IPL size and GCL cellularity
(asterisks) in Dyrk1A+/ and tgYAC152f7-B retinas
compared with Dyrk1A disomic (Dyrk1A+/+ and
Dyrk1A+//tgYAC152f7-B) retinas. The scale bar
is 40 mm.
(B) Histograms showing the total thickness of the
retina, the thickness of each retina layer, and the
number of cells in the GCL in mice of the same
genotypes as in (A).
(C–N) Retina sections from Dyrk1A+/ and
tgYAC152f7 mice and their control littermates
(Dyrk1A+/+ and wild-type, respectively) immuno-
stained with antibodies specific for cells of the
INL (anti-PKCa in [C]–[F] and anti-CyclinD3 in [G]–
[J]) and the GCL (anti-Brn3b in [K]–[N]); sections
are counterstained with hematoxylin. Somata of
PKCa-positive cells (arrowhead in [D] and [F]),
and nuclei of CyclinD3-positive cells (arrowhead
in [H] and [J]) show normal location within the
mutant retinas. Note the presence of abnormally
located PKCa-positive cell bodies in tgYAC152f7
retina (asterisk in [F]). The scale bar is 40 mm.
(O) Histograms showing the numbers of PKCa- and
CyclinD3 (CyD3)-positive cells relative to the total
number of cells in the INL, and of Brn3b-positive
cells relative to the total number of cells in the
GCL, in mutant and control retinas.
Values in the histograms correspond to the
means ± SD (*p < 0.05 and **p < 0.001).
control littermates and have a thinner ret-
ina, whereas tgYAC152f7 eyes are bigger
and have thicker retinas (Figures S2C and
S2D). Although the lamination of this
structure is preserved in both strains,
the relative sizes of the different layers
seemed altered (Figures S2E and S2F).
Quantification of transverse eye sections
showed an average size reduction of
25% in Dyrk1A+/ mutant retinas com-
pared with controls. The sizes of the outer
nuclear layer (ONL) and OPL were normal
in this mutant, whereas the INL and IPL
were thinner than those in control mice
(Figure S2G; Table S2). The size reduc-
tion observed in the INL of Dyrk1A+/ ret-
inas is due to a decrease in cell number, as cell body diameters
and cell densities were not significantly different between geno-
types (Table S3). In addition, Dyrk1A+/ retinas showed a de-
crease of 40% in the number of cells that compose the GCL
(Figure S2G). This reduction in retina size and cellularity does
not appear to be caused by a degenerative process, because
the degree of cell loss in the INL and GCL was similar in 22- to
25-month-old Dyrk1A+/ mice (Table S4). Therefore, the retina
cell number alterations in Dyrk1A+/ mice are produced during
844 Developmental Cell 15, 841–853, December 9, 2008 ª2008 Elsevier Inc.
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an average size increase of 23% compared with that in controls.
As with Dyrk1A+/ mice, the size alteration in tgYAC152f7 mice
did not affect the ONL and OPL, but only affected the INL and
IPL sizes (Figure S2H; Table S2). In addition, a significant in-
crease in GCL cellularity was also observed in transgenic
animals (Figure S2H). These results suggest that the number of
retina inner cells depends on the amount of DYRK1A. To provide
further evidence for this, we examined retinas of the progeny of
crosses between Dyrk1A+/ mice and transgenic mice bearing
only one copy of the YAC clone 152f7 (tgYAC152f7-B). The
phenotypes of mice bearing one copy (Dyrk1A+/) or three cop-
ies (tgYAC152f7-B) of Dyrk1A were very similar to those de-
scribed above, confirming the effect of gene-dosage variation
in retina development (Figure 3A). As anticipated, mice bearing
the YAC clone 152f7 but disomic for Dyrk1A (Dyrk1A+//
tgYAC152f7-B) have normal amounts of DYRK1A protein
(Figure S2I), and, most importantly, the size of their eyes and
of the different retina layers were undistinguishable from those
of wild-type Dyrk1A disomic (Dyrk1A+/+) mice (Figure 3B;
Figure S2J).
To further investigate these alterations in cellularity, we as-
sessed whether all inner retina cell types were present in both
mutant strains. For this, we used antibodies against the following
cell-type-specific proteins: anti-protein kinase C a (PKCa) to
label rod BP cells (Ghosh et al., 2004), anti-calbindin and anti-
calretinin for AMA cell subtypes (Haverkamp and Wassle,
2000), anti-cyclin D3 for Mu¨ller glial (MG) cells (Dyer and Cepko,
2000), and anti-Brn3b for RGCs (Xiang et al., 1995). Positive cells
for each of the antibodies tested were detected in both loss- and
gain-of-function mutant retinas in the same layer position as in
wild-type retinas (Figures 3C–3N; Figure S3). This result indi-
cates that RPCs with altered Dyrk1A dosage are able to differen-
tiate into the main cell types that compose the inner retina and
migrate through the developing retina to their normal final desti-
nation in the adult. However, in accordance with the significant
alterations in cell numbers observed in the inner layers of Dyrk1A
mutant retinas (Figure 3B), the total number of positive cells for
each of the inner retina cell markers tested was significantly
decreased in Dyrk1A+/ and increased in tgYAC152f7 retinas
when compared with those in their corresponding controls.
One of the most striking alterations detected in both Dyrk1A mu-
tants was to the number of Brn3b-positive RGCs (Table S5).
RGCs are the only projecting neurons of the retina, and each
cell gives rise to a single axon that exits the eye as part of the
optic nerve (ON) (Jeon et al., 1998). We therefore examined ON
sections of Dyrk1A+/ and tgYAC152f7 mice, as an independent
measure of RGCs number. The mean cross-sectional area of
Dyrk1A+/ ON was significantly smaller (Dyrk1A+/+: 91422 ±
21254 mm2, Dyrk1A+/: 49106 ± 8785 mm2; p < 0.01), and the
average number of axons was around half that in controls
(Dyrk1A+/+: 29666 ± 4639 axons, Dyrk1A+/: 16012 ± 2359
axons; p < 0.005). Conversely, the mean cross-sectional area
of tgYAC152f7 ON was bigger (tgYAC152f7: 104888 ± 14223
mm2, wild-type: 68098 ± 6722 mm2; p < 0.05) and the number
of axons higher than in controls (tgYAC152f7: 38160 ± 5893
axons, wild-type: 24977 ± 2550 axons; p < 0.05). These results
confirm the altered numbers of RGCs found in both Dyrk1A
mutants.
Despite the fact that the numbers of all retina cell types
examined were reduced in Dyrk1A+/ retinas, estimation of the
numbers of PKCa-, CyclinD3-, and Brn3b-positive cells as a pro-
portion of total cell number within a layer revealed increased
ratios of rod BP and GM cells and decreased ratios of RGCs in
Dyrk1A+/ retinas relative to controls. Interestingly, these
changes in cell type ratios appear to go in opposite directions
in tgYAC152f7 retinas (Figure 3O). Although our analysis covers
a few of the different subtypes of cells identified so far in the
mouse INL and GCL, it clearly shows that changes in Dyrk1A
dosage do not influence the different cell types that form these
two cell layers equally. As no significant differences were
observed in the morphology of OPL and IPL synaptic terminals
(Figure S4), our data suggest that the visual dysfunction
Figure 4. Alteration of Dyrk1A Gene Dosage Modifies the Number of
Inner Retina Cells in Newborn Mice
(A and B) Representative medial retina sections from eyes of (A) embryos and
(B) pups of the indicated genotypes immunostained with anti-Brn3b antibody.
At (A) E14.5, the location and number of positive cells are similar in mutant and
control retinas. At (B) PND6, the size of the retina and the number of positive
cells are severely altered in the mutants. Asterisks in (B) mark the position
of the nascent OPL, which is not visible in the tgYAC152f7 retina due to its
increased size. Scale bars are 100 mm in (A) and 20 mm in (B).
(C) Quantification of Brn3b-positive cells per section in PND3, PND6, and
PND16 mutant and control mice. Values correspond to the means ± SD
(*p < 0.05 and **p < 0.001).
(D) Representative medial retina sections from mutant and control pups at
PND6 showing a normal distribution of Chx10-positive cells in all sections.
The scale bar is 40 mm.
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DYRK1A Regulates Apoptosis in Mouse Retinaobserved in Dyrk1A mutant mice results from a developmental
defect that leads to the altered cell numbers and the altered
proportions of INL and GCL cells reported here.
Inner Retina Cells Are Generated Normally in Dyrk1A+/
and tgYAC152f7 Mice
The phenotypes described above suggest a possible defect in
the generation of inner retina cells during development. RGCs,
which are the first-born cells in the retina (Cepko et al., 1996;
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Figure 5. Altered Apoptosis during Periods
of Naturally Occurring PCD in Dyrk1A
Mutants
(A and B) Representative medial retina sections
from (A) embryos and (B) pups of the indicated ge-
notypes showing a normal distribution of phospho-
Histone H3 (pH3) in all sections. Dashed squares
represent a 23 magnification of pH3 cells. Scale
bars are 100 mm in (A) and 20 mm in (B).
(C) Quantification of total pH3-positive cells in ret-
ina sections from E14.5 and E18.5 embryos and
PND1 mice, and of pH3-positive cells per section
in PND3 and PND6 mice.
(D) Representative medial retina sections from
eyes of E18.5 mutant and control embryos show-
ing apoptotic cells positive for active Casp3. The
scale bar is 40 mm.
(E) Quantification of total active Casp3-positive
cells in retina sections from E14.5 and E18.5 em-
bryos and PND1 mice, and of active Casp3 cells
per section in PND3 and PND6 mice.
(F) Histograms showing the number of active
Casp3 cells in whole retinas treated with 100 mM
Casp9 inhibitor (LEHD), 100 mM Casp8 inhibitor
(IETD), or DMSO as vehicle.
(G) Quantification of total active Casp9-positive
cells in retina sections from E18.5 embryos.
Values in the histograms correspond to the
means ± SD (*p < 0.05, **p < 0.001, ***p < 0.0001).
Farah and Easter, 2005; Young, 1985),
are the population most severely affected
by changes in Dyrk1A dosage, and a de-
fect in their generation could explain the
changes observed in the other cell popu-
lations (Figure 3O) (Brown et al., 2001;
Wang et al., 2001). Therefore, we aimed
to determine whether these cells are gen-
erated properly in Dyrk1A mutants. At
E14.5, the distribution of Brn3b-positive
RGCs and the area of the neuroretina
stained with the Brn3b antibody were sim-
ilar in all genotypes (Figure 4A) (Dyrk1A+/+:
29% ± 3%, Dyrk1A+/: 28% ± 5%, p >
0.5; wild-type: 38% ± 2%, tgYAC152f7:
39% ± 2%, p > 0.5). An identical situation
was observed at E18.5 when RGCs gene-
sis is almost complete (data not shown).
Interestingly, it was only after birth that
the number of Brn3b-expressing cells
became markedly different in the mutants
compared with their control littermates: reduced in the loss-
of-function model and increased in the gain-of-function model
(Figures 4B and 4C). Similarly, the distribution of cells stained
with an antibody against Chx10, a transcription factor expressed
in other differentiating inner retina cells (Liu et al., 1994), was
normal at postnatal stages, although the number of positive
cells seemed altered in both mutant mice (Figure 4D). Accord-
ingly, neuroretina size was normal at embryonic stages but
was abnormal postnatally (Figures 4A and 4B; total retina
846 Developmental Cell 15, 841–853, December 9, 2008 ª2008 Elsevier Inc.
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p < 0.005; wild-type: 175 ± 7 mm, tgYAC152f7: 198 ± 7 mm, p <
0.05). These results indicate that embryonic retinogenesis is ap-
parently normal in Dyrk1A+/ and tgYAC152f7 mice, and more-
over suggest that changes in Dyrk1A dosage do not affect the
specification of inner retina cells.
Correct Dyrk1A Dosage Is Essential for the Survival
of Retina Cells during Development
To examine whether DYRK1A might regulate cell number
through an influence on RPC proliferation, we counted phospho-
histone H3-positive cells as a marker of mitotic cells. Dyrk1A+/
and tgYAC152f7 mice at embryonic and postnatal stages
showed no differences in the number and distribution of positive
cells compared with their corresponding wild-type littermates
(Figures 5A–5C). This result thus suggests that alterations in
cell death, rather than proliferation, are likely responsible for
the altered retina size and cell numbers observed in both mutant
models.
To determine the extent of PCD in Dyrk1A+/ and tgYAC152f7
retinas, we counted the number of active caspase-3 (Casp3)-
positive cells during development, starting from E14.5, when
the first cell death wave takes place, to PND16, when the retina
is already mature and developmental PCD is almost undetect-
able (Boya and de la Rosa, 2005; Young, 1984). At E14.5, the
number and distribution of active Casp3-positive cells were nor-
mal in both models (Figure 5E and data not shown). In contrast,
at perinatal stages, coinciding with the period of differentiating
RGC death (Farah and Easter, 2005; Young, 1984), the number
of cells expressing active Casp3 was significantly increased in
Dyrk1A+/ mice and reduced in tgYAC152f7 mice (Figures 5D
and 5E). Similar alterations in the number of cells expressing
active Casp3 were observed later in development (Figure 5E),
when other cell types, mainly AMA cells and BP cells, also die
by apoptosis in the INL (Farah and Easter, 2005; Young, 1984).
No differences in the number of active Casp3 cells were
observed between mutant and wild-type mice at PND16 (data
not shown). These results indicate that abnormal apoptosis in
both mutant models occurs in the same time frame as develop-
mental PCD in wild-type mice.
Apoptotic cell death is triggered either through the extrinsic
pathway, with caspase-8 (Casp8) as the main mediator, or
through the intrinsic pathway, mediated by activation of Casp9
(Kumar, 2007; Riedl and Salvesen, 2007). Data from different
mouse models indicate that fine regulation of the intrinsic
apoptotic pathway is crucial for retina development (Guerin
et al., 2006; Isenmann et al., 2003). Experiments in freshly iso-
lated whole retinas from wild-type PND5 mice further supported
the importance of this apoptotic pathway in retina cell death,
since the pharmacological inhibition of Casp9 activation, but
not that of Casp8, significantly decreased apoptotic cell death
(Figure 5F). To assess the implication of DYRK1A in Casp9-
mediated apoptosis, we counted the number of active Casp9
cells in E18.5 Dyrk1A mutant embryos, and found that numbers
were increased in the loss-of-function model and decreased in
the gain-of-function model (Figure 5G). These differences are
equivalent to the differences observed in active Casp3 cells
(3.6-fold in Dyrk1A+/ and 1.7-fold in tgYAC152f7, with respect
to controls), suggesting that abnormal apoptosis in Dyrk1A
mutants occurs through the intrinsic apoptotic pathway.
DYRK1A Regulates Casp9 Apoptotic Activity
by Phosphorylation at Thr125
Casp9 activation is considered to be a crucial link connecting cell
signaling and apoptotic execution. Several regulatory mecha-
nisms have been reported to act at the level of Casp9 precursor
D
α-HA
α-GFP
115 
 kDa
 Blot:
HA-DYRK1A WT KR WT KR WT KR WT KR WT KR WT KR
82 
64 
48 
37 
GFP
CASP9
DYRK1A
input IP α−GFP 
GFP-CASP9 GFP WT T125A GFP WT T125A
SQPAVGNLTPVVLGPEELWPARLKPEVLRPETPRPVDIGSGGAHDVCVP 142
SKPTLENLTPVVLRPEIR-----KPEVLRPETPRPVDIGSGGFGDVGAL 142hCASP9
mCasp9
RPX(T/S)P Consensus sequence
A
C
120 
82 
α-PiT125
α-GFP
 kDa
 Blot:
GFP-CASP9
GFP-DYRK1A WT WT WT KR KRKR
120 
82 
CASP9
DYRK1A
B
GST-CASP9108-173
GST
GST-DYRK1A WT WT KR WT KR
+
WT WT WTT125A T125A T125A
36
24 
36 
24 
Autoradiography
Coomassie blue
WT
GST
GST-CASP9108-173
 kDa
Figure 6. DYRK1A Interacts with Casp9 and Phosphorylates It at
Thr125
(A) Comparison of human (hCASP9, amino acids 99–142) and mouse
(mCasp9, amino acids 132–180) Casp9 sequences, showing the conservation
of Thr125 in the human sequence as part of the DYRK1A consensus phosphor-
ylation motif (boxed).
(B) Unfused GST and the fusion proteins GST-CASP9108–173 wild-type (WT)
and GST-CASP9108–173-T125A (T125A) were used as substrates in in vitro
kinase assays with GST-DYRK1A WT or kinase-dead DYRK1A-K179R (KR),
in the presence of radio-labeled ATP. Reactions were resolved by SDS-
PAGE and analyzed by autoradiography. The gel was stained with Coomassie
blue to control for equal loading of the recombinant proteins.
(C) Cell lysates from HEK293T cells transfected with two different amounts of
a plasmid encoding Casp9 (C287A) and either the WT or the kinase-dead
mutant version (KR) of GFP-DYRK1A were immunoblotted with anti-
phosphoThr125 Casp9 (PiT125) and anti-GFP antibodies.
(D) Cell lysates from HEK293T cells transfected with the indicated plasmids
(GFP-fused Casp9 WT = C287A, TA = C287A+T125A; HA-tagged DYRK1A
WT = wild-type; KR = K179R) were immunoprecipitated with anti-GFP
antibody, and samples were immunoblotted with anti-HA and anti-GFP anti-
bodies. Inputs represent 10% of total soluble cell extracts.
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DYRK1A Regulates Apoptosis in Mouse Retinaactivation, or to prevent active Casp9 from reaching its sub-
strates (Callus and Vaux, 2007). One of them, phosphorylation
of Casp9 on Thr125, inhibits Casp9 cleavage and activation
(Allan et al., 2003). Thr125 lies within a consensus amino acid se-
quence for DYRK1A phosphorylation (Figure 6A) (Himpel et al.,
2000). To test if DYRK1A indeed phosphorylates this Casp9
residue, we performed in vitro kinase assays with bacterially
expressed proteins. Our results show that wild-type DYRK1A
phosphorylated a Casp9 fragment containing Thr125, whereas
a kinase-dead mutant did not (Figure 6B). Thr125 is the only
phosphorylation site for DYRK1A in Casp9, as mutation of this
residue to alanine completely abrogated radioactive phosphate
incorporation in the Casp9 fragment and in the full-length
Casp9 protein (Figure 6B and data not show). We confirmed
DYRK1A-dependent phosphorylation of Casp9 at Thr125 in
mammalian cells by immunoblot with a specific anti-phos-
phoThr125 antibody. PhosphoThr125 signal markedly increased
when Casp9 was coexpressed with wild-type DYRK1A, but not
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Figure 7. The Phosphorylation of Casp9 at Thr125 by DYRK1A
Protects Cells from Apoptosis in the Retina
(A) Representative western blots of total lysates prepared from retinas of PND5
Dyrk1A+/ (+/) and tgYAC125f7 (YAC) pups, and their control littermates
(+/+ and WT, respectively), analyzed with PiT125 and Casp9 antibodies. The
PiT125 antibody recognizes several bands, but only the one indicated with
an arrow responds to okadaic acid treatment, which stabilizes phosphoryla-
tion of Thr125 by the inhibition of phosphatases (Allan et al., 2003; Dessauge
et al., 2006).
(B) Histograms showing the phosphorylation levels of PiT125 relative to the
total amount of Casp9 in retina lysates from PND5 +/, +/+, YAC, and WT
pups. Mean values were obtained from three independent litters.
(C) Active Casp3 immunopositive cells in whole retinas isolated from
Dyrk1A+/+, Dyrk1A+/, wild-type, and tgYAC125f7 PND5 pups. The scale bar
is 20 mm.
(D and E) Histograms showing the number of active Casp3 cells in whole
retinas isolated from (D) Dyrk1A+/+ and Dyrk1A+/ pups or from (E) wild-type
and tgYAC152f7 pups, treated with 100 mM LEHD or DMSO.
Values in the histograms correspond to the means ± SD (*p < 0.05 and
***p < 0.0001).848 Developmental Cell 15, 841–853, December 9, 2008 ª2008 Elswhen coexpressed with the kinase-death mutant DYRK1A-
K179R (Figure 6C). We also assessed whether DYRK1A and
Casp9 interact by coimmunoprecipitation experiments and
showed that DYRK1A was present in Casp9 immunocomplexes,
indicating specific interaction between the two proteins. This
interaction is independent of DYRK1A kinase activity and of
the phosphorylation status of Thr125 in Casp9 (Figure 6D).
To investigate the relevance of DYRK1A-dependent phos-
phorylation of Casp9 in the retina, we determined the levels of
phosphoThr125 in postnatal retina extracts prepared from both
Dyrk1A mutant strains and found that levels were decreased in
Dyrk1A+/ mice and increased in tgYAC152f7 mice (Figures 7A
and 7B). To address whether DYRK1A could be the kinase re-
sponsible for Casp9 phosphorylation at the inhibitory Thr125
site in the retina, we took advantage of harmine, an inhibitor of
DYRK1A kinase activity (Bain et al., 2007). We showed that
harmine acts as an ATP-competitive inhibitor in in vitro kinase
assays, and inhibits DYRK1A kinase activity in vivo, measured
as the autophosphorylation capability of DYRK1A on serine
520 (phosphoSer520) (Figure S5). Treatment of isolated wild-
type whole retinas with harmine decreased the levels of phos-
phoSer520 and phosphoThr125 in a concentration-dependent
manner. Importantly, inhibition of Erk, a kinase that also phos-
phorylates Casp9 at Thr125 (Allan et al., 2003) and that partici-
pates in DYRK1A-regulated signaling pathways (Aranda et al.,
2008; Kelly and Rahmani, 2005), did not affect the phosphoryla-
tion levels of Thr125 Casp9 and Ser520 DYRK1A, while signifi-
cantly reduced the levels of phosphoErk (Figures S6A and
S6B). Together these results indicate that DYRK1A is the major
kinase phosphorylating Casp9 in the retina.
To assess the significance of DYRK1A-dependent phosphor-
ylation of Casp9 on retina cell survival we determined the number
of apoptotic cells in whole retinas treated with harmine. Inhibition
of DYRK1A activity with harmine increased the numbers of active
Casp9 and active Casp3 cells (Figures S6C–S6F). Moreover,
treatment of whole retinas with the Casp9 inhibitor LEHD
protected retina cells from the apoptosis induced by harmine in-
hibition (Figures S6G and S6H). As anticipated, isolated retinas
from Dyrk1A-deficient mice showed a significant increase in
the numbers of active Casp3 cells that was completely abolished
upon Casp9 inhibition (Figures 7C and 7D), further indicating that
DYRK1A-dependent phosphorylation at Thr125 of Casp9 pro-
tects retina cells against apoptosis. Interestingly, the protective
effect conferred by DYRK1A overexpression in tgYAC152f7
whole retinas was equivalent to the protective effect conferred
by inhibition with LEHD (Figures 7C and 7E). These results indi-
cate that Casp9 is a relevant target for DYRK1A in its prosurvival
effect on retina developmental PCD.
DISCUSSION
In this work, we show that DYRK1A protein kinase is essential for
retina development and in particular, for the correct execution of
the Casp9-mediated apoptotic cell death program. An altered
Dyrk1A gene dose leads to changes in the number of retina cells,
with increases in retinas from transgenic animals overexpressing
DYRK1A and decreases in Dyrk1A+/ retinas. The defects are
more prominent in specific neural cell populations, supporting
the notion that changes in DYRK1A protein levels differentiallyevier Inc.
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shown in the brain (Arque et al., 2008; Fotaki et al., 2002, 2004).
A large number of mutant mice that show altered retina pheno-
types have been described. However, most of these involve
degeneration of first-order neurons (Chang et al., 2002). Here,
we describe two mutant animal models with severe visual
impairment mainly resulting from alterations in second- and
third-order retina neurons. Previous reports of mutant mice
with ERG responses similar to those elicited in Dyrk1A+/ mice
also described defective retina development leading to alter-
ations in cell number and structural connectivity (Bramblett
et al., 2004; Brzezinski et al., 2005; Rice et al., 2001). These
morphological and functional similarities support the finding
that ERG deficits in Dyrk1A+/ mice are mainly caused by the
reduced numbers and altered proportions of inner retina cells
reported here. Although we are not aware of any report showing
altered ERG responses in a mouse model with retina hyperpla-
sia, it is tempting to speculate that most of the ERG deficits in
tgYAC152f7 mice could be caused by the increased numbers
and altered proportions of inner retina cells in these mice. Taken
together, our results clearly show that changes in the amount of
DYRK1A have detrimental effects on retina function. Moreover,
the altered electrophysiological responses measured in
tgYAC152f7 mice opens the possibility that overexpression of
DYRK1A contributes to the visual deficits in DS (Courage et al.,
1994; John et al., 2004; Little et al., 2007; Woodhouse et al.,
1996). Whether or not this is in fact the case needs further study
in the different DS trisomic mouse models that are available
(Salehi et al., 2007).
Themnb gene inDrosophila plays an important role in postem-
bryonic neurogenesis (Tejedor et al., 1995), and mnb hypomor-
phic mutants have similar brain phenotypes to Dyrk1A+/ mice.
These parallels, and the activities of other DYRK family members
in the regulation of cell cycle progression in lower eukaryotes
(Bahler and Nurse, 2001; Garrett et al., 1991; Souza et al.,
1998), have lead to the assumption that DYRK1A has a con-
served role during evolution in the regulation of neuronal progen-
itor cell proliferation. However, our analysis of developing retinas
in loss- and gain-of-function Dyrk1A mutant mice indicates that
the main role of DYRK1A in this CNS structure is related to cell
death/survival, rather than cell proliferation. In the retina, cells
are generated in excess, and some die by apoptosis soon after
they are born. In the mouse, this occurs in two phases: an early
phase mainly affecting proliferating neuroepithelial cells (Boya
and de la Rosa, 2005), and a later phase affecting differentiating
cells, and which accounts for the majority of developmental cell
death (Bahr, 2000). We propose that DYRK1A is a negative mod-
ulator of naturally occurring apoptosis during developmental
PCD in the retina.
Our results with caspase inhibitors indicate that Casp9, in the
intrinsic apoptotic pathway, is the main mediator of caspase-
dependent cell death in the retina. The relevance of this pathway
to retina development was previously highlighted by the hyper-
cellularity of the inner retina layers of transgenic mice overex-
pressing the antiapoptotic gene Bcl-2 (Bonfanti et al., 1996;
Strettoi and Volpini, 2002) and of mice lacking the proapoptotic
proteins Bax, Bak, or Bim (Doonan et al., 2007; Hahn et al., 2003;
Mosinger Ogilvie et al., 1998; Pequignot et al., 2003). The nor-
mal-sized ONL of these mutants can be explained by the factDevelopmthat developmental PCD in PRs only occurs in a small percent-
age of rods trapped in the INL (Young, 1985). The similarities
between the retina phenotypes ofDyrk1Amutant mice and these
mutants, together with the altered numbers of active Casp9 cells
in Dyrk1A mutants, strongly indicate that DYRK1A is a negative
modulator of retinal PCD, acting through the intrinsic cell death
pathway.
Phosphorylation of Casp9 has been described in cell lines as
a regulatory mechanism used by different signaling pathways
to promote cell survival (Allan et al., 2003; Brady et al., 2005;
Cardone et al., 1998). In particular, phosphorylation at Thr125
inhibits Casp9 cleavage and activation of subsequent steps of
the intrinsic apoptotic cell death pathway (Allan and Clarke,
2007; Allan et al., 2003). Based on the following findings, we
propose that phosphorylation at Thr125 of Casp9 by DYRK1A
is crucial for retina cell survival: (1) appropriate Dyrk1A dosage
is necessary for the correct activation of Casp9 in the retina;
(2) DYRK1A directly phosphorylates Casp9 at Thr125; (3) the
levels of phosphoThr125 in Dyrk1A mutant retinas directly corre-
late with the levels of DYRK1A protein; (4) DYRK1A kinase activ-
ity is required to protect cells from apoptosis; and, finally, (5)
Casp9 inhibition abrogates the increase in cell death induced
by inhibition of DYRK1A kinase activity and by heterozygous
deletion of the Dyrk1A gene. We cannot exclude additional
DYRK1A-dependent mechanisms acting upstream of Casp9
activation, although this seems unlikely given the fact that
none of the DYRK1A substrates identified so far (Dierssen and
de Lagran, 2006) have been directly implicated in the intrinsic ap-
optotic machinery, and that we found no alterations in Dyrk1A
mutant retinas in Bcl-2 proteins whose apoptotic activity is reg-
ulated by phosphorylation (Kutuk and Letai, 2008) (data not
shown).
Prosurvival roles have been identified for other mammalian
DYRK kinases in hematopoietic cells (Li et al., 2002), myoblasts
(Mercer et al., 2005), and cancer cells (Chang et al., 2007; Deng
et al., 2006; Mercer et al., 2006). In addition, DYRK1B and
DYRK3 have been identified in a large-scale RNA interference
screen for kinases involved in cell survival (MacKeigan et al.,
2005). All of these data highlight the relevance of DYRK protein
kinases to cell survival during development and to tumor forma-
tion and progression. Our results add a new member of the
DYRK kinases into the list of potential targets for the develop-
ment of therapeutic approaches for cancer.
Studies with Casp9 knockout mice have revealed an essential
role for Casp9 in brain development. The most outstanding
phenotype in these animals is brain hyperplasia resulting from
decreased apoptosis (Hakem et al., 1998; Kuida et al., 1998).
Dyrk1A+/ and tgYAC152f7 mice have abnormally sized brains
in adulthood (Branchi et al., 2004; Fotaki et al., 2002). The mech-
anism/s underlying this phenotype is/are still unknown, but our
demonstration here that these mice have developmental defects
affecting the intrinsic apoptosis pathway suggests that dysregu-
lation of the same functional processes might be at the basis of
the retina and brain phenotypes. If so, altered developmental
apoptosis due to increased amounts of DYRK1A might explain
some of the morphometric brain alterations reported in DS indi-
viduals (Epstein, 2001; Rachidi and Lopes, 2007). Based on
studies in Drosophila DYRKs (Lochhead et al., 2005), DYRK1A
is thought to be a constitutively active kinase. This could explainental Cell 15, 841–853, December 9, 2008 ª2008 Elsevier Inc. 849
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makes an important contribution to DS.
In this study, we demonstrate that DYRK1A regulates the
apoptotic program in the retina through the phosphorylation of
Casp9 at the inhibitory Thr125 site. In addition, our work contrib-
utes to the understanding of the cellular mechanisms regulated
by this pleiotropic kinase in the nervous system.
EXPERIMENTAL PROCEDURES
Mice
The generation of Dyrk1A+/ mice and of transgenic mice expressing the YAC
clone 152f7 (tgYAC152f7), which contains five HSA21 genes including
DYRK1A, is described elsewhere (Fotaki et al., 2002; Smith et al., 1997).
Two different tgYAC152f7 lines were used in this study: line A, containing
three copies of the YAC DNA, and line B, containing only one (Branchi et al.,
2004). Experiments were done with (1) Dyrk1A+/ mice and their wild-type
littermates (Dyrk1A+/+), resulting from crosses between C57BL/6J-129S2/
SvHsd Dyrk1A+/ and C57BL/6J-129S2/SvHsd wild-type mice and with (2)
tgYAC152f7 mice and their wild-type littermates, resulting from crosses
between line A FVB tgYAC152f7 and C57BL/6 wild-type mice. To obtain
tgYAC152f7 mice disomic for Dyrk1A (Dyrk1A+//tgYAC152f7-B), crosses
between line B FVB tgYAC152f7 (tgYAC152f7-B) and CD-1 Dyrk1A+/ mice
were performed. Animals of the same gender were used to compare the visual
phenotype in adults. All experimental procedures were carried out according
to the guidelines of the European Union and by following protocols approved
by the corresponding local ethics committee.
Electroretinography
Electroetinogram (ERG) recordings were performed in deeply anesthetized
and dark-adapted mice. Recordings were taken between a mouse electrode
fixed on a corneal lens over the mouse eye (Burian-Allen electrode, Hansen
Ophthalmic Development Lab), a reference electrode located in the mouth,
and a ground electrode located on the tail. After pupil dilatation, flash-induced
ERG responses were recorded from the right eye in response to light stimuli
produced with a Ganzfeld stimulator. Light stimuli intensities ranged from
4 to 2 log cd$s$m2 and for each intensity, 4–64 consecutive light presenta-
tions were averaged. Each range of flashes allowed recording of particular
responses: from 4 to 1.52 for rod-mediated responses; from 1.52 to
0.48 for mixed rod and cone responses; of 0.48 and at a recording frequency
range of 100–1000 Hz for OPs; from0.52 to 2 log cd$s$m2 on a rod-saturat-
ing background of 30 cd/m2 for cone-mediated responses; and at 1.48 log
cd$s$m2 on a rod-saturating background for flicker responses (20 Hz). The
ERG signals were amplified and band filtered between 0.3 and 1000 Hz (Grass
CP511 AC amplifier), digitized at 10 kHz with a Power Lab data acquisition
board (ADI instruments), and analyzed off-line by measuring the amplitudes
of the a-wave (from the baseline to the trough of the a-wave) and of the
b-wave (from the trough of the a-wave to the peak of the b-wave). ERG mea-
surements were taken by an observer blinded to the experimental condition of
the animals (n = 5–12 per group).
Cell Number Counts and Immunostaining
Adult, postnatal, and embryo tissues were processed for histology essentially
as described in Fotaki et al. (2002). Retina layer thickness, cell numbers, cell
densities, and cell soma diameters were measured in sections stained with
cresyl violet acetate by using the CAST GRID stereological software from
Olympus. Morphometrical evaluation of ONs was performed in toluidine blue
sections as described in Fernandez et al. (1991). Retina sections were pro-
cessed for immunohistochemistry by using the avidin-biotin-peroxidase
method (Vectastain ABC kit, Vector labs). Counting of immunopositive cells
was performed in one complete series covering the whole optic cup from
embryo sections, and in complete medial retina sections with ON from isolated
optic cups (n = 3 per genotype). Experimental details on tissue preparation for
histology, morphometric analysis and cell counts, immunostaining procedures
with a list of antibodies, and on the transmission electron microscopy data
presented in Figure S4 are in Supplemental Data.850 Developmental Cell 15, 841–853, December 9, 2008 ª2008 ElsPlasmids, Cell Culture, Transfection, Immunoprecipitation,
and Western Blot Analysis
The expression plasmids pHA-DYRK1A, pGFP-DYRK1A, and pGST-DYRK1A,
and their corresponding kinase-dead K179R mutant have been described in
Alvarez et al. (2007) and (2003). Plasmids pGFP-CASP9 WT/C287/T125 and
pGST-CASP9 WT/T125 were generated by PCR amplification by using the
IMAGE Consortium human cDNA clone IRAUp969DO29D6 as template and
the QuickChange site-directed mutagenesis kit (Stratagene). HEK293T cells
were cultured and transiently transfected as described in Alvarez et al.
(2007). Whole-cell extracts were prepared in SDS buffer. Soluble cell extracts
for immunoprecipitation were prepared in lysis buffer A and incubated over-
night at 4C with protein G-Sepharose beads (GE Healthcare) prebound with
1 mg anti-GFP antibody (Molecular Probes). Whole-tissue extracts from
isolated retinas were prepared in SDS buffer by pooling the retinas of a mini-
mum of two animals. Samples were resolved by SDS-PAGE and analyzed
by immunoblot. Buffers for cell extract preparation and antibodies for western
blot analysis are provided in Supplemental Data.
In Vitro Kinase Assays
Unfused GST, GST-CASP9 WT, or T125A immobilized on glutathione-Sephar-
ose 4B beads were incubated for 20 min at 30C in 40 ml kinase buffer (50 mM
HEPES [pH 7.4], 0.5 mM DTT, 5 mM MgCl2, 5 mM MnCl2) containing 50 mM
ATP, [g32P]ATP (1 3 103 mCi/pmol) and 50 ng purified GST-DYRK1A WT or
K179R. Reactions were stopped by the addition of 63 Laemmli buffer, and
samples were resolved by SDS-PAGE and then stained with Coomassie
blue. 32P incorporation was detected by autoradiography of dried gels.
Conditions for purification of GST fusion proteins and details on the DYRKtide
kinase assay used in the experiments shown in Figure S5 are provided in
Supplemental Data.
Whole-Retina Treatments
Isolated retinas from PND5 pups were maintained in 4-well plates with
500 ml/well DMEM:F12 medium in an incubator at 37C for 90 min, with or
without the different inhibitors at the concentrations indicated: harmine (TCI
Europe), norharmane (Sigma), PD98059 (LC Laboratories), Casp9 inhibitor
Z-LEHD-FMK (Calbiochem), and Casp8 inhibitor Z-IETD-FMK (Calbiohem).
After treatment, whole-retinas were processed for immunofluorescence
analysis. Quantifications were done from four fields around the ON head per
retina (n = 4–5 animals per genotype).
Statistical Analysis
In all experiments, the significance of differences between groups was
evaluated by analysis of variance, followed by a two-tailed Student’s t test.
Quantitative data are presented as the mean ± standard deviation (SD).
Differences were considered significant at p values < 0.05: *p < 0.05,
**p < 0.001, and ***p < 0.0001.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, six
figures, and five tables and can be found with this article online at http://
www.cell.com/developmentalcell/supplemental/S1534-5807(08)00474-7/.
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